A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Actinic Keratosis
Interventions
DRUG

PEP005 gel

Two day application, 0.05%

Trial Locations (4)

75703

Dermatology Associates of Tyler, Tyler

92117

Skin Surgery Medical Group Inc, San Diego

30078-3250

Gwinnett Clinical Research Centre, Snellville

78229-3409

Dermatology Clinical Research Centre of San Antonio, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Omnicare Clinical Research

INDUSTRY

lead

Peplin

INDUSTRY